Skip to content

To study the effect of a Weightloss program in overweight humans.

A monocentric, two group, placebo controlled, randomized study to evaluate the efficacy of Plix Program (Plix Apple Cider Vinegar Effervescent tablets, diet, exercise) on weight management, Visceral Adiposity Index & lipid profile in obese-1 subjects and the in-use tolerance of the product

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054909
Enrollment
68
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories

Interventions

Intervention1: Test Group Plix Apple Cider Vinegar Effervescent tablets plus Diet and exercise recommendations: 2 tablets per day to be taken. 1 Tablet 30 mins before lunch and 1 Tablet 30 mins befor

Sponsors

Plix Life
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Voluntary women and or men from 18 years to 55 years of age, willing to lose weight. 2. With the body mass index (BMI) of more than 25 kg/m2 (range 25– 3. Subjects not on any nutritional supplement or not consuming any therapeutic medication for any disorder for last 45 days. 4. Subjects with no known allergies to foods & other substances 5. Cooperating, informed of the need and duration of the examinations, and ready to comply with protocol procedures. 6. Having signed a Consent Form, after being informed orally and in writing of all information concerning the study procedures and study objectives. 7. Willingness to avoid intense UV exposure as far as possible for the entire study duration.

Exclusion criteria

Exclusion criteria: 1. Pregnant women by UPT /lactating women. 2. Subjects showing abnormal levels in blood test parameters. (Subjects having abnormal values but are Clinically fit to participate in the trial would be enrolled in the study at Principal Investigator’s Discretion). 3. Subjects regularly taking ACV for the past 1 month. 4. Having conditions like thyroid, diabetes, gastrointestinal diseases or any kind of infections. 5. Any clinically significant systemic disease, which may interfere with study treatments or procedures. 6. Subjects with substance abuse (alcohol, drugs). 7. Subject likely to undergo any surgery in the period of the study. 8. Subjects who were on any other experimental Investigational study within last 1 month as identified during screening on visit 1 (V1). 9. Individuals with chronic Gastrointestinal issues such as frequent indigestion, bloating, acidity or GERD.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Plix Program (Plix Apple Cider Vinegar Effervescent tablets, diet, exercise) on weight management, Visceral Adiposity Index & lipid profile in obese1 subjects versus baseline & placebo. Timepoint: Screening, Day 0, 1 month, 2 month, 3 month

Secondary

MeasureTime frame
To evaluate the in-use tolerance of the product.Timepoint: Screening, Day 0, 1 month, 2 month, 3 month

Countries

India

Contacts

Public ContactMs Preetha Paul

C.L.A.I.M.S. Pvt. Ltd.

preetha@claimsclinical.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026